HELP / INFO
Ready? Click this button to continue
Home Button: Returns you to the start/main menu.
Next Button: This takes you to the next page.
Back Button: This takes you to the previous
page.
Accessibility Button: This shows the controls
to
change contrast, font size, and color.
Full Screen Button: This toggles fullscreen on
and off.
Click Button: Interactive elements marked with this icon can be clicked.
Drag Button: Interactive elements marked with this icon can be moved.
Replay Button: This button replays the course.
Exit Button: This button closes the course.
PAX-US-0212
This video has been developed by Emergent BioSolutions Inc. for informational purposes only and does not constitute medical advice or recommendations.
Important Safety Information
Vaxchora is contraindicated in people with a history of severe allergic reaction (e.g.,
anaphylaxis) to any
ingredient of Vaxchora or to a previous dose of any cholera vaccine.
The safety and effectiveness of Vaxchora have not been established in immunocompromised persons.
Vaxchora may be shed in the stool of recipients for at least 7 days. There is a potential
for transmission
of the vaccine strain to non-vaccinated close contacts(e.g., household contacts). Use
caution when
considering whether to administer Vaxchora to individuals with immunocompromised close
contacts.
The most common adverse reactions (incidence >3%) were tiredness (31%), headache (29%),
abdominal pain (19%), nausea/vomiting (18%), lack of appetite (17%), and diarrhea (4%).
Important Safety Information
Vaxchora is contraindicated in people with a history of severe allergic reaction (e.g.,
anaphylaxis) to any
ingredient of Vaxchora or to a previous dose of any cholera vaccine.
The safety and effectiveness of Vaxchora have not been established in immunocompromised persons.
Vaxchora may be shed in the stool of recipients for at least 7 days. There is a potential
for transmission
of the vaccine strain to non-vaccinated close contacts(e.g., household contacts). Use
caution when
considering whether to administer Vaxchora to individuals with immunocompromised close
contacts.
The most common adverse reactions (incidence >3%) were tiredness (31%), headache (29%),
abdominal pain (19%), nausea/vomiting (18%), lack of appetite (17%), and diarrhea (4%).
Important Safety Information
Vaxchora is contraindicated in people with a history of severe allergic reaction (e.g.,
anaphylaxis) to any
ingredient of Vaxchora or to a previous dose of any cholera vaccine.
The safety and effectiveness of Vaxchora have not been established in immunocompromised persons.
Vaxchora may be shed in the stool of recipients for at least 7 days. There is a potential
for transmission
of the vaccine strain to non-vaccinated close contacts(e.g., household contacts). Use
caution when
considering whether to administer Vaxchora to individuals with immunocompromised close
contacts.
The most common adverse reactions (incidence >3%) were tiredness (31%), headache (29%),
abdominal pain (19%), nausea/vomiting (18%), lack of appetite (17%), and diarrhea (4%).